-
Zofran Linked to Birth Defects by Four Studies
Posted By Golomb & Honik
||
11-May-2015
The drug Zofran (Ondansetron) has been linked by at least four studies to an increased risk of birth defects. Zofran was approved by the FDA in 1991 only for the treatment of nausea experienced by chemotherapy and radiation patients, as well as for patients who experienced nausea following a surgical procedure. Zofran officials, however, touted the drug to doctors as a cure for severe morning ...
Continue Reading
-
Zofran Lawsuit Charges GlaxcoSmithKline with Failure to Warn
Posted By Golomb & Honik, P.C.
||
15-Apr-2015
A recent lawsuit filed in the U.S. District Court of the District of Massachusetts charges GlaxcoSmithKline, the manufacturer of the drug Zofran, with failure to warn pregnant patients of the potential risks of birth defects when Zofran is used in the first trimester. The victim and her family is asking for compensatory and punitive damages due to birth defects. The child, born in 2000, has ...
Continue Reading
-
Alleged FDA and J&J Risperdal Cover Up Exposed
Posted By Golomb & Honik
||
24-Mar-2015
Earlier this year, the U.S. Food and Drug Administration was sued in Pennsylvania federal court. The suit claims that the FDA barred a law firm from turning over confidential Risperdal documents, which were obtained through the discovery process. This directly resulted in the denial of a citizen petition asking that Johnson & Johnson publicize documents relating to the dangers of the ...
Continue Reading
-
Daiichi Sankyo Agrees to Pay $39 Million to Settle Benicar Kickback Allegations
Posted By Golomb & Honik
||
24-Mar-2015
2015 did not start very well for pharmaceutical company Daiichi Sankyo. In January 2015, the company agreed to pay the United States and state Medicaid programs $39 million after allegations surfaced that they paid physicians kickbacks to prescribe drugs, such as Azor, Benicar, Tribenzor, and Welchol. This is in direct violation of the False Claims Act and the Anti-Kickback Statute. The ...
Continue Reading
-
Testosterone Lawsuits Move Forward
Posted By Golomb & Honik, P.C.
||
21-Mar-2015
Plaintiffs who have suffered heart attack, stroke or death, due to the use of testosterone supplements, will finally see their cases moving forward. U.S. District Judge Matthew F. Kennelly recently met with attorneys arguing the testosterone cases in order to discuss future case management strategies. The testosterone cases have been consolidated in a federal multidistrict litigation in the U.S. ...
Continue Reading
-
Xarelto Lawsuit MDL Created in Pennsylvania
Posted By Golomb & Honik, P.C.
||
20-Mar-2015
Despite the fact that some Xarelto lawsuits have been coordinated in Federal Court in New Orleans, while others have been coordinated in State Court in Philadelphia, manufacturers Bayer and Johnson & Johnson continue to push the FDA for Xarelto approvals. There are hundreds of lawsuits on file with plaintiffs claiming adverse health issues and even death as a result of taking Xarelto. In light ...
Continue Reading
-
Public Citizen Petitions FDA to Recall Fungal Drug Ketoconazole
Posted By Golomb & Honik, P.C.
||
14-Mar-2015
The consumer advocacy group Public Citizen has recently petitioned the FDA to recall the fungal medication ketoconazole due to concerns over an increased risk of liver damage. In their statement to the FDA, Public Citizen made the following claims: The risk of liver damage far outweighs the "questionable" benefits of this drug The FDA sent an internal memo in 2013 that classified the ...
Continue Reading
-
Granuflo Lawsuits Rising
Posted By Golomb & Honik
||
1-Mar-2015
As of February 2015, more than 2,575 lawsuits are pending against Fresenius in the District of Massachusetts federally-filed GranuFlo MDL. The lawsuits claim Fresenius knew-or should have known-about the increased risk of death and serious injury associated with GranuFlo, and that those risks were concealed and misrepresented by Fresenius Medical Care. Lawsuits seek punitive damages in addition to ...
Continue Reading
-
Patients Taking Xarelto Don't Know There is NO Antidote
Posted By Golomb & Honik, P.C.
||
28-Jan-2015
Those patients taking the blood thinner, Xarelto, still don’t know that they are at an increased risk for bleeding to death. That’s because Xarelto manufacturers have kept that secret pretty well hidden. Now, lawsuits across the country are cropping up, after patients taking Xarelto have bled to death or experienced serious injury. Unlike traditional blood thinners, Coumadin or ...
Continue Reading
-
FDA Delays Issuing New Generic Drug Label Rule
Posted By Golomb & Honik
||
31-Dec-2014
A new proposed rule that will allow generic drug makers to update their own safety warnings on labels has been delayed until the fall of 2015. The new rule has been labeled as “controversial” because it would give the makers of generic drugs the ability independently update safety warnings. This is currently something that only brand-name drug makers are allowed to do prior to ...
Continue Reading
-
Xarelto Lawsuits Seek MDL Status
Posted By Golomb & Honik, P.C.
||
19-Dec-2014
Hearings to determine whether or not to consolidate Xarelto Bleedout Lawsuits are scheduled for December 2014. Court documents indicate that multidistrict litigation status for Re: Xarelto Products Liability Litigation has been proposed by six plaintiffs who are also lobbying to have an additional 21 Xarelto Bleedout Lawsuits consolidated in MDL status for the Southern District of Illinois. ...
Continue Reading
-
First Benicar Wrongful Death Case Filed
Posted By Golomb & Honik
||
6-Nov-2014
In the past year, Benicar has been the focus of numerous lawsuits. Each lawsuit alleged that the dangerous drug caused victims to develop sprue-like enteropathy and other severe GI complications. Now, however, a different lawsuit is being filed against the manufacturers of Benicar-a wrongful death lawsuit. This is the first lawsuit that alleges the dangerous drug Benicar directly caused or ...
Continue Reading
-
Naproxin Bottles Recalled Due to Packaging Error
Posted By Golomb & Honik, P.C.
||
5-Nov-2014
If you recently purchased Assured brand naproxen sodium at Dollar Tree or through the Dollar Tree website, you may have inadvertently purchased ibuprofen. Due to a packaging error, 11,640 boxes were mistakenly filled with the wrong softgel pills. The mistake and recall was announced via a press release issued by the U.S. Food and Drug Administration (FDA) on October 20, 2014. The press release ...
Continue Reading
-
The Dangers of Testim
Posted By Golomb & Honik
||
24-Oct-2014
Auxilium Pharmaceuticals received FDA approval on October 31, 2002 for Testim, a testosterone supplement administered via transdermal patches or gel applied to the upper arms and shoulders on a daily basis. Testim was only approved for use among men with very low testosterone levels or those who have stopped producing the hormone altogether; however, huge numbers of men across the nation are being ...
Continue Reading
-
FDA Cracks Down on Children's Cold Medicine Labels
Posted By Golomb & Honik
||
15-Oct-2014
When your child is sick, you want to trust that the medicine you give them is safe and effective. But when pharmaceutical companies fail to adequately label their products, the consequences can be severe. The United States Food and Drug Administration (FDA) recently released draft guidelines intended to make children's cold medicines safer. The new guidelines specifically address ...
Continue Reading
-
FDA Issues Warning over Dangerous Drugs in Weight Loss Supplements
Posted By Golomb & Honik
||
11-Oct-2014
Weight loss is a multi-billion dollar per year industry. While some products and services truly do help people lead healthier lifestyles, many are nothing more than modern day snake oil. And, in some cases, they are downright dangerous. If a dangerous drug or supplement has caused you pain and suffering, the attorneys at Golomb & Honik can help you recover the compensation you deserve. The ...
Continue Reading
-
Actos Lawsuits Claim Takeda Placed Profits over Safety
Posted By Golomb & Honik
||
11-Oct-2014
Pharmaceuticals save countless lives every year, and there's no question that society has benefited greatly from the increased quality of life and lifespan that modern medicine offers. However, drug companies too often take advantage of consumers by prioritizing profits over product safety. Simply put, this is unacceptable, and these pharmaceutical companies must be held accountable for the ...
Continue Reading
-
FDA Warns Mixing Supplements with Prescription Meds can be Dangerous
Posted By Golomb & Honik
||
18-Sep-2014
The U.S. Food and Drug Administration (FDA) recently announced that it may be dangerous to take certain vitamins and/or dietary supplements while also taking certain medications. The FDA’s announcement, which was published on October 27 and titled Mixing Medications and Dietary Supplements Can Endanger Your Health, stresses the fact that dietary supplements have the potential to either ...
Continue Reading
-
Lawsuits Against Benicar Manufacturers Begin
Posted By Golomb & Honik, P.C.
||
14-Aug-2014
In 2013, the FDA warned the general public about the dangers of Benicar and required its manufacturers to update the warning label. These dangers included developing a serous GI disorder, known as sprue-like enteropathy, which can lead to severe malnutrition, diarrhea, and dehydration. Now, injured patients are beginning to file lawsuits across the country, seeking to hold the negligent ...
Continue Reading
-
Johnson & Johnson Recalls Hysterectomy Device Due to Cancer Concerns
Posted By Golomb & Honik, P.C.
||
7-Aug-2014
Medical product and device manufacturer Johnson & Johnson decided to recall a medical device that is utilized during hysterectomies and other uterine procedures after it received reports that the device might spread undetected cancer in patients. The device is one that shaves tissue into small pieces that can be removed without the need for open surgery. The Food and Drug Administration (FDA) ...
Continue Reading
-
Yaz and Yasmin Lawsuits Still Being Filed
Posted By Golomb & Honik, P.C.
||
24-Jul-2014
In spite of the massive number of dangerous drug lawsuits already filed against Bayer Pharmaceuticals in association with the birth control medications Yasmin and Yaz, there are still many more claims on the way. Currently, there are 3,900 Yasmin and Yaz claims pending, and approximately 7,660 plaintiffs have already settled with the pharmaceutical company. At the moment, Bayer has paid ...
Continue Reading
-
Bristol-Myers Initiates Blood Thinner Recall
Posted By Golomb & Honik
||
2-Jul-2014
According to the US Food and Drug Administration (FDA), Bristol-Myers Squibb Co has initiated a voluntary recall of their blood thinner, Coumadin. The pharmaceutical company decided to recall six lots of the injectable version of this blood thinner after finding particulate matter in some unreleased samples. Bristol-Myers called the recall a “precautionary measure” and claimed there ...
Continue Reading
-
What Are the Side Effects Associated with the Mirena IUD?
Posted By Golomb & Honik, P.C.
||
24-Apr-2014
The Mirena IUD is a popular birth control device used by more than 15 million women around the world. It consists of a small, T-shaped device that gets inserted into the uterus and gradually releases hormones in order to prevent pregnancy for up to 5 years. While Bayer Healthcare Pharmaceuticals, Inc. has marketed the device as one of the most effective forms of contraception available, these ...
Continue Reading
-
Recent da Vinci Recall Addresses Faulty Instrument Arms as Robotic Surgical Device Lawsuits Mount
Posted By Golomb & Honik, P.C.
||
13-Feb-2014
Already facing mounting lawsuits related to its da Vinci Surgical System, Intuitive Surgical recently initiated a voluntary recall to repair or replace faulty instrument arms on certain robot-assisted surgery devices. Our Philadelphia-based consumer class action attorneys at Golomb & Honik, P.C. are dedicated to helping victims of dangerous medical devices pursue the financial peace of mind ...
Continue Reading
-
Attorneys Investigate Johnson & Johnson Talc Powder and Ovarian Cancer Claims
Posted By Golombg & Honik
||
31-Jan-2014
The national consumer class action attorneys at Golomb & Honik are actively investigating claims on behalf of women who may have developed ovarian cancer following the regular use of talcum-based Johnson & Johnson powder products for feminine hygiene. If you or someone you love was diagnosed with ovarian cancer that may be associated with the use of a Johnson & Johnson powder, please ...
Continue Reading
26 results found. Viewing page 1 of 2.
Go to page